enthusiasm dramatically outpaces science FDA Category 2 classifications for peptides like Semax reflect absence of FDA-standard evidence, not documented harmsRussian clinical experience suggests reasonable safety, but long-term effects by Western standards remain uncharacterized Established interventionsexercise, Mediterranean diet, sleep optimization, cardiovascular risk management, cognitive engagementhave far more consistent evidence than any peptide for dementia risk reduction For Research Prioritization Compounds meriting continued investigation: GLP-1 Agonists: Prevention trials in preclinical/presymptomatic populations, testing compounds with better brain penetration (dulaglutide, lixisenatide) SS-31/Elamipretide: Cognitive outcomes in mitochondrial disease populations, potential expansion to brain aging indications P21: Phase I human trials to establish safety, pharmacokinetics, and proof-of-mechanism for CNTF-pathway neurogenesis Klotho: Watch for Phase 1 results from Jocasta Neuroscience (expected 2027-2028)
Cognitive peptides (Semax, Selank) Stability: Lyophilized: 2-3 years frozen Reconstituted: 28-30 days refrigerated Intranasal use = frequent access to vial Storage tips: Reconstitute 2-4 week supply Keep refrigerated between uses Nasal spray bottles: Replace every 2-3 weeks Protect from light See our Semax peptide dosage guide , Selank peptide injection dosage , peptides for anxiety , and best peptide for energy and focus
Acknowledgements We express our gratitude to the Vice-Chancellor for Research, Isfahan University of Medical Sciences for financial support through the scientific code 398979 and grant number 1989096
These results suggested that hypoxia stress may play an initiating or promoting role in the pathogenesis of -syn-related diseases such as PD and DLB
